Roivant Sciences
Roivant Sciences
American pharmaceuticals company
Drug Discovery
Biotechnology
Clinical Research
Data Analytics
Regulatory Affairs
Poultry Science Headquarters, Texas, United States
501-1,000
Founded in 2014 (12 years ago)
Hybrid
Private
Valuation
20.7B
Total funding
$3.0B
Last round
unknown
Open roles at Roivant Sciences
0 open roles
No open positions at this time
Products and services
VA
Vant Discovery Platform
Technology Platform
BA
Batoclimab
Biopharmaceutical
BR
Brepocitinib
Biopharmaceutical
RO
Roivant Discovery Services
Services
GI
Gimsilumab
Biopharmaceutical
VA
Vant Portfolio Companies
Business Model
DR
Drug Discovery Platform
Technology Platform
DI
Digital Health Solutions
Digital Health
RV
RVT-3101
Ophthalmology
RV
RVT-2001
Dermatology
RO
Roivant Discovery
Technology Platform
AU
Autoimmune Portfolio
Immunology
RV
RVT-1401
Neurology
Leadership
VR
Vivek Ramaswamy
Founder
Similar companies
Intellia
Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Cambridge, MA
201-500 employees
Public
Valuation $1.2B
3 open jobs
CRISPR Therapeutics
Swiss-American biotechnology company
Cambridge, Massachusetts, United States
201-500 employees
Public
Valuation $2.9B
16 open jobs
Bio-Rad
Global leader in life science research and clinical diagnostics
Hercules, California, United States
5,001-10,000 employees
Public
Valuation $3.2B
Insulet
Multinational healthcare company.
Bedford, Massachusetts, United States
501-1,000 employees
Public
Valuation $2.1B
Exact Sciences
American company in Madison, Wisconsin
Madison, Wisconsin, United States
5,001-10,000 employees
Public
Valuation $3.2B
276 open jobs
Latest updates
All
X
News
HN
YouTube
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman - Yahoo Finance
Yahoo Finance
News
·
2 months ago
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Potential 30% Upside in Healthcare Biotech - DirectorsTalk Interviews
DirectorsTalk Interviews
News
·
2 months ago
Roivant Sciences Ltd.
The following individuals sold restricted/control securities in the past week. **Venker Eric** * Value of securities sold: $5.9M * Sold in the prior 3 months: $11.1M [Source](https://www.sec.gov/Archives/edgar/data/0001635088/000196530126000044/xsl144X01/primary_doc.xml) *Roivant Sciences Ltd. is headquartered in London.*
·
2 months ago
·
1
Buy Signal Roivant Sciences Ltd - 23 Apr 2026 @ 11:23 -> USD28.65
Ticker: **ROIV** Exchange: **NASDAQ** Time: **23 Apr 2026 @ 11:23** Price: **USD28.65** Link: https://getagraph.com/NASDAQ/stock/live-signals/ROIV/ENG
·
3 months ago
·
1
Roivant Sciences(ROIV.US) Officer Sells US$5.92 Million in Common Stock - Moomoo
Moomoo
News
·
3 months ago
Show 15 more
Total Views
0
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Reviews
4.0
10 reviews
Work-life balance
2.8
Compensation
4.2
Culture
4.1
Career
3.5
Management
3.8
72%
Recommend to a friend
Pros
Innovative and cutting-edge projects
Supportive team and colleagues
Excellent benefits and compensation
Cons
Poor work-life balance
High pressure and stress
Heavy workload
Salary Ranges
15 data points
Intern
Intern
0 reports
$119,560
total per year
Base
-
Stock
-
$101,646
$137,474
Contact and location